Experts are recommending cardiometabolic screening in certain race/ethnic minority populations, prior to the onset of overweight or obesity.
It follows findings from a new study which showed individuals from four racial/ethnic minority groups had a statistically significantly higher prevalence of metabolic abnormality but normal weight (MAN). While the prevalence of MAN was 21 per cent in Whites, the rate was 32.2 per cent in Chinese Americans, 31.1 per cent in African Americans, 38.5 per cent in Hispanics, and 43.6 per cent in South Asians. Although the study was undertaken in the US, the authors say the prevalence was not explained by demographic, behaviour or ectopic fat measures.
“The key message for clinicians is that using overweight and obesity as the main criteria to screen for high blood pressure, high glucose, high triglycerides, or low HDL cholesterol will likely miss a substantial number of people who have high cardiometabolic risk but are of normal weight,” said first author Unjali Gujral.
Testing for cardiometabolic abnormalities in normal-weight and underweight members of high-risk groups may also be an important consideration, Gujral added.